show episodes
 
Artwork

1
RCA Radio

Regulatory Compliance Associates

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
RCA Radio covers the latest news and challenges in regulatory, compliance, and quality assurance facing the medical device, pharmaceutical, and biologic industries. In each episode, join Regulatory Compliance Associates® (RCA) and industry thought leaders as we navigate the issues that matter to you most.
  continue reading
 
Artwork

1
DarshanTalks Podcast

Darshan Kulkarni

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
Welcome to DarshanTalks! We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there! Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do. We focus on life science issues ...
  continue reading
 
Welcome to Food Tech Talk: Supply Chain Insights From Farm to Fork, a bite-sized podcast discussing the latest trends and technology in the food and supplements industries, featuring conversations with regulatory experts, quality and safety champions, and thought leaders across the industry. Together, we are on a mission to change the food and dietary supplement industry for the better. In short snippets, guests will discuss a range of topics, from regulatory compliance to sustainable operat ...
  continue reading
 
Artwork

1
Hemp Legally Speaking

Jonathan Miller - National Leading Hemp Attorney & Advocate

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
With hemp being legalized only recently, legal and regulatory regimes concerning the crop and its products such as CBD are continually evolving. Jonathan Miller, who helped craft much of federal and state hemp laws in his role as General Counsel of the US Hemp Roundtable, hosts a biweekly podcast in which he engages in 15-20 minute discussions of cutting-edge legal issues facing the industry. Jonathan speaks on each program with subject matter experts from Frost Brown Todd’s nationally leadi ...
  continue reading
 
Artwork

1
AHLA's Speaking of Health Law

American Health Law Association

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly+
 
The American Health Law Association (AHLA) is the largest nonprofit, nonpartisan educational organization devoted to legal issues in the health care field. AHLA's Speaking of Health Law podcasts offer thoughtful analysis and insightful commentary on the legal and policy issues affecting the American health care system.
  continue reading
 
Artwork

1
Quality Grind Podcast

MEDVACON Life Sciences

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly+
 
Welcome to The Quality Grind Podcast, presented by Medvacon! Join hosts Joe Toscano, President of Medvacon, and Mike Kent, Director of Learning Platforms, as they (we) have some fun while tackling topics related to the “everyday grind” within Life Science industries. Featuring conversations with key industry players, they’ll dive into their unique problem-solving strategies, career paths and personal interests. Most importantly, their (our) goal is to cultivate a community where information ...
  continue reading
 
Nectar is an award-winning product development company based in southern California. Our product design and development process is an interdisciplinary approach combining industrial design, user experience design, mechanical engineering, and electrical engineering that ensures product designs are successfully executed into production. We’ve been helping clients design products that connect to their users and expand their markets for over 30 years. We are firm believers in the team approach t ...
  continue reading
 
Artwork

1
PwC's Next in Health

PwC's Health Industries

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Co -hosted by Glenn Hunzinger, US Health Industries leader, and Jennifer Colapietro, Consulting Commercial Leader, the Next in Health podcast series offers insights on the most important issues facing pharma, medtech and healthcare. PwC business leaders discuss the latest trends and their impact on health industries, whether it’s policy, AI, innovation, care delivery, business model reinvention or bold moves for the future. If it’s happening in health industries, we’re talking about it.
  continue reading
 
Navigate every market. Accelerate every launch. Medical Device Global Market Access by Pure Global is the audio briefing that turns the world’s most confusing regulatory pathways into clear, actionable roadmaps. If you’re a MedTech founder, RA/QA leader, product manager, or investor who needs to get devices cleared anywhere from Austin to Abu Dhabi, this show is your shortcut. Why listen? • Step-by-step playbooks – We decode EU MDR, U.S. 510(k), Brazil’s ANVISA, China’s NMPA, and 25 + other ...
  continue reading
 
Artwork

1
$1 Pound Show

CannabisPermits.com

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
The $1 Pound Show dives deep into the cannabis industry. We discuss and document the transition happening with marijuana. From the black market to grey market finally to a regulated market. California has recently legalized cannabis and is currently figuring out it's regulations. Guests include, cultivators, extractors, lawyers, doctors other business owners.
  continue reading
 
I Wish I Knew What I Know Now: Conversations With AGG on FDA Issues is a legal podcast hosted by Arnall Golden Gregory LLP. In this podcast series, different members of our Food & Drug practice and colleagues in other related life science teams will discuss issues and challenges they have encountered when assisting clients on business and legal matters.
  continue reading
 
Artwork

1
Anesthesiology News Presents

Anesthesiology News, James Prudden, Paul Bufano

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Anesthesiology News will be publishing a new season of our popular podcast series, “On the Case” and “Ask the Experts.” “On the Case” is a review series that features the authors of our popular case report series. We hear the behind-the-scenes story on the most unique clinical case studies published in the magazine directly from the professionals who managed them. The first episode of this new season features an interview with L. Jane Stewart, MD, JD, MPH, who co-wrote a case report about a ...
  continue reading
 
Artwork

1
16 Minutes News by a16z

Andreessen Horowitz

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
16 Minutes on the News is a short news podcast where we cover the top headlines of the week, the a16z podcast way -- why are these topics in the news; what's real, what's hype from our vantage point; and what are our experts' quick takes on these trends? About the a16z Podcast: Discusses tech and culture trends, news, and the future -- especially as ‘software eats the world’. It features industry experts, business leaders, and other interesting thinkers and voices from around the world. This ...
  continue reading
 
Artwork

1
MAKING IT TO MARKET - WITH DAHLIA KELADA

Making it to Market - Dahlia Kelada

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
On the "Making it to Market" podcast, we discuss everything about brand inception and product/service creation through to commercialization. Industry experts and business owners are invited to share their insights and best practices related to business planning, legal and regulatory considerations, manufacturing, supply chain, marketing, merchandising, B2B buyer methodology and B2C consumer psychology.
  continue reading
 
Loading …
show series
 
In a groundbreaking development for the digital health world, Eli Lilly, one of the world’s largest pharmaceutical companies, has filed lawsuits against a growing number of telehealth companies over the sale of compounded drugs Mounjaro and Zepbound, two popular GLP-1 medications. Nawa Lodin, Associate, Wilson Sonsini Goodrich & Rosati, and Lauren …
  continue reading
 
Tom Donohoe, Shareholder, Hall Render Killian Heath & Lyman PC, Kelly Adams, Region General Counsel, Intermountain Health, and Barb Grandjean, Partner, Husch Blackwell LLP, discuss the various labor and employment considerations that are present in health care transactions, with a focus on the current M&A environment. They cover issues related to p…
  continue reading
 
Did you know that oysters are not only popular items at seafood festivals, but vital to the health of our estuaries? Join Food Sleuth Radio host and Registered Dietitian, Melinda Hemmelgarn for her conversation with Sandra Brooke, Ph.D., research faculty at Florida State University’s Coastal and Marine Laboratory and scientific director and lead in…
  continue reading
 
This episode provides a comprehensive guide to CE Marking for medical devices, a mandatory certification for accessing the European Economic Area. We cover the essential requirements, including device classification, Quality Management Systems, technical documentation, conformity assessments by Notified Bodies, clinical evaluations, the role of the…
  continue reading
 
In this episode of RCA Radio, host Brandon Miller sits down with Jessica Schafersman, a design and development expert at RCA®, to break down the increasingly complex world of combination products—those that blend drugs, devices, or biologics. Jessica shares insights on why these products are uniquely challenging, the regulatory expectations compani…
  continue reading
 
In this must-listen episode for pharma marketers and corporate counsel, we break down the recent $14.25M False Claims Act settlement involving Diopsys, a neurodiagnostic company accused of offering free tech to physicians—tech that allegedly led to medically unnecessary tests billed to Medicare and Medicaid. This wasn’t just bad billing—it was a ma…
  continue reading
 
Send us a text Join host Mike Kent and special guest Jose Mora as they continue to explore the application of Lean principles within regulated life science environments. In this episode, they explore seven key benefits of Lean: quality and compliance, throughput and operating expense reduction, speed to market, flexibility and adaptability, continu…
  continue reading
 
This episode provides a comprehensive overview of the U.S. FDA's medical device approval process. We break down the three device risk classifications, detail the primary regulatory pathways including Premarket Notification (510(k)), Premarket Approval (PMA), De Novo, and Humanitarian Device Exemption (HDE). Listeners will also learn about the gener…
  continue reading
 
This episode unpacks the evolving world of medical device regulatory compliance. We explore crucial updates, including the FDA's QMSR Final Rule effective February 2026 and its alignment with ISO 13485:2016. We also cover diverse global frameworks, core compliance components like QMS and risk management, common challenges, and strategic approaches …
  continue reading
 
Rob Gerberry, Senior Vice President and Chief Legal Officer, Summa Health, speaks with Michael Peregrine, Partner, McDermott Will & Emery, about the Department of Justice Criminal Division’s recent release of its new white collar criminal enforcement plan and the board’s oversight responsibility for corporate compliance with the law. They discuss h…
  continue reading
 
In this episode, we talk to Martin Van Trieste about Civica Rx, nonprofit pharmaceutical company designed to address drug shortages in the U.S. The company focuses on sterile generics and biosimilars that have become economically unviable for other manufacturers. Initially operating as a broker, Civica transitioned into manufacturing, filing multip…
  continue reading
 
This episode explores the dynamic field of wearable medical devices. The host discusses the various types, from smartwatches to specialized sensors, their key functions in monitoring, screening, detection, and prediction, and the significant benefits they offer for patient empowerment, remote care, and chronic disease management. The discussion als…
  continue reading
 
Jonathan Miller interviews Justin Swanson, President of the Midwest Hemp Council, about legislation being considered by the House Appropriations Committee that could ban most consumable hemp products. If you have questions about the episode or ideas for Hemp related topics, email us at [email protected]. Hemp Industry questions covered…
  continue reading
 
This episode explores the cutting-edge medical device technologies set to revolutionize healthcare in 2024 and 2025. We delve into advancements in noninvasive wearables, home care systems, surgical tools, AI-driven diagnostics, and specialized treatments for cardiovascular, orthopedic, and neurological conditions, highlighting how these innovations…
  continue reading
 
In this discussion, Joseph Wolfson, an attorney at Stevens and Lee, and Darshan explore the intersection of law, marketing, and compliance in the pharmaceutical and medical device industries. Joe focuses on both antitrust litigation and advising private equity firms, pharmaceutical companies, and medical device companies on legal matters, particula…
  continue reading
 
This episode delves into the critical role of insurance for medical device companies in the USA. We explore the two main facets: securing product liability insurance to mitigate operational and legal risks, and navigating the health insurance reimbursement landscape to ensure patient access and commercial viability. We cover key steps like FDA appr…
  continue reading
 
This episode demystifies "HIPAA compliance" for medical devices. The host explores when manufacturers become subject to HIPAA, the essential administrative, physical, and technical safeguards for protecting patient health information (PHI), patient rights regarding their data, requirements for data sharing and Business Associate Agreements, and the…
  continue reading
 
Operation Brace Yourself, a massive 2019 Department of Justice operation involving the durable medical equipment (DME) industry, was one of the largest health fraud enforcement actions in history and had major legal and compliance repercussions for DME companies. In this two-part series, Stephen Lee, Solo Practitioner, Law Office of Stephen Chahn L…
  continue reading
 
Did you know that consolidation in the fertilizer industry results in environmental harm and less choice for farmers? Join Food Sleuth Radio host and Registered Dietitian, Melinda Hemmelgarn for her conversation with Basel Musharbash, antitrust and trade regulation lawyer, and author of Kings Over the Necessaries of Life: Monopolization and the Eli…
  continue reading
 
In this episode, Darshan Kulkarni and Edye Edens explore whether sites should consider whistleblowing on non-compliant sponsors. They acknowledge that non-compliance is a non-negotiable issue, but emphasize the difficulty of deciding when to report, especially given the financial and relational ties between sites and sponsors. They discuss examples…
  continue reading
 
This episode demystifies ISO 13485 certification, explaining how it signifies a robust Quality Management System for medical device organizations. We explore the certification process, its broad applicability across the device lifecycle, the stringent requirements for risk management and regulatory compliance, and its crucial role in ensuring produ…
  continue reading
 
On this episode of Culture & Compliance Chronicles, Amanda Raad and Nitish Upadhyaya from Ropes & Gray’s Insights Lab, and Richard Bistrong of Front-Line Anti-Bribery, are joined by Nicole Rose, a compliance specialist and creative artist based in Australia who shares her unique insights on how creativity helps solve compliance challenges. Nicole d…
  continue reading
 
This episode delves into proven strategies for medical device companies to identify, vet, and secure local importers and distributors worldwide. We explore a multifaceted approach, combining digital tools, key industry events, professional networks, and crucial due diligence steps to help you effectively expand your product's global reach and navig…
  continue reading
 
Send us a text Welcome back to the Grind, where Joe and Mike continue their exploration of Cell & Gene Therapy with expert Ray Kaczmarek. In this episode, part 2 of our 4-part series, Ray provides perspective on navigating the development process, highlighting some key factors for success – robust science, integrous data and stage-appropriate syste…
  continue reading
 
This episode delves into the dominant force in medical device revenue: In Vitro Diagnostics (IVDs). We uncover why IVDs consistently lead the global market, highlighting key drivers like early disease detection and the rise of chronic illnesses. We also explore the geographical strongholds, with a focus on the U.S. market's supremacy, and identify …
  continue reading
 
Building a strong food safety culture requires deep organizational commitment and the systematic implementation of best practices across every level of operations. In this episode of Food Tech Talk: Supply Chain Insights from Farm to Fork, host Lydia Adams is joined by Dinesh Babu, Vice President of Quality and Food Safety at State Garden, for an i…
  continue reading
 
Operation Brace Yourself, a massive 2019 Department of Justice operation involving the durable medical equipment (DME) industry, was one of the largest health fraud enforcement actions in history and had major legal and compliance repercussions for DME companies. In this two-part series, Stephen Lee, Solo Practitioner, Law Office of Stephen Chahn L…
  continue reading
 
On this episode of Fully Invested, Ropes & Gray asset management partner Jessica Marlin and capital markets counsel Marc Rotter discuss ’34 Act Registered Private Funds. These funds register under the Securities Exchange Act of 1934 and disclose information publicly, while remaining exempt from the Investment Company Act of 1940. Jessica and Marc e…
  continue reading
 
In this episode, Darshan Kulkarni sits down with Marie Ange Noue, Senior Director and Head of Scientific Communications at EMD Serono, to dive deep into the increasingly common practice of medical affairs teams creating dedicated LinkedIn handles. Marie explains that this trend is driven by healthcare professionals’ evolving preferences for receivi…
  continue reading
 
This episode explores the evolving global market entry strategies for medical devices. We discuss the significant regulatory hurdles in the EU due to MDR/IVDR, leading manufacturers to increasingly prioritize the U.S. market. We also delve into the burgeoning opportunities in high-growth emerging markets across Asia-Pacific and Latin America, offer…
  continue reading
 
This episode delves into the three essential pillars for medical device companies aiming to expand their reach from local to international markets. We discuss the critical nature of understanding diverse international regulatory landscapes and the role of harmonization efforts. We also explore the importance of in-depth market research, effective p…
  continue reading
 
In this episode, Edye and Darshan dive into the controversial but critical question: Are we paying patients enough to participate in clinical trials? And if not, how can we ethically and compliantly pay them more? Key Takeaways: The Coercion Concern Compensation for trial participation is often scrutinized by IRBs due to concerns around coercion. H…
  continue reading
 
CE marking is a crucial certification for medical devices, acting as a legal key to the European market and a global benchmark for safety and quality. It signifies compliance with strict EU regulations (MDR/IVDR), offers competitive advantages, and provides a solid foundation for other international regulatory approvals, making it essential for man…
  continue reading
 
This episode unpacks the significant variations in "Class III" and "Class IV" medical device classifications across key global markets like the US, EU, Canada, China, and Saudi Arabia. We explore why a device's risk class in one country doesn't automatically apply elsewhere and what this means for manufacturers seeking international market access.K…
  continue reading
 
Did you know that consolidation in our food and agriculture systems has more to do with the price of eggs than bird flu? Join Food Sleuth Radio host and Registered Dietitian, Melinda Hemmelgarn for her conversation with Basel Musharbash, antitrust and trade regulation lawyer, and author of Kings Over the Necessaries of Life: Monopolization and the …
  continue reading
 
This episode unpacks the 2025 landscape for the FDA's Breakthrough Devices Program and the transformative new CMS Transitional Coverage for Emerging Technologies (TCET) pathway. We explore how these initiatives are accelerating device clearance and Medicare coverage, including the impact of over 1,000 Breakthrough designations granted by September …
  continue reading
 
Google’s 2024 ad safety report just sent shockwaves through the pharma and device industries. With AI now faster, smarter, and more ruthless, Google blocked over 5.1 billion ads last year and restricted 9.1 billion more. Healthcare ads were hit especially hard, with over 106 million healthcare and medicine ads being blocked. If you’re still relying…
  continue reading
 
Send us a text Welcome to The Grind! Hosts Joe Toscano and Mike Kent caught up with special guest Ray Kaczmarek in San Diego for an insightful discussion highlighting the complexities and dynamic nature of Cell and Gene Therapy. In this episode, the first in a 4-part series, Ray shares his experiences from military service to multiple C-suite roles…
  continue reading
 
This episode provides a comprehensive guide to navigating the complex global regulatory landscape for Software as a Medical Device (SaMD), with a special focus on AI-enabled technologies. We explore SaMD risk classifications in key markets like the US, EU, and Canada, discuss recent AI-specific guidance from bodies like the FDA (including the Decem…
  continue reading
 
Tune in as Glenn Hunzinger, PwC’s Health Industries Leader, and Phil Scalfani, PwC’s Pharmaceutical and Life Sciences Consulting Leader, discuss the Trump administration’s executive order on Most Favored Nation (MFN) drug pricing and its far-reaching implications across the healthcare ecosystem. They break down what MFN pricing could mean for pharm…
  continue reading
 
This episode delves into China's transformative 2025 NMPA Roadmap, detailing how the "NMPA regulation 2025" aims to accelerate approvals for innovative medical devices. We explore the new Special Review Pathway, shortened clinical trial timelines, priority review categories, and expanded domestic production opportunities, offering insights for manu…
  continue reading
 
Jackie Selby, Partner, Epstein Becker & Green PC, Maria Nikol, CEO, Revelar Analytics LLC, and Karen Mandelbaum, Senior Counsel, Epstein Becker & Green PC, discuss current trends and developments related to price transparency. They cover why price transparency is important; provide an overview of the hospital transparency rule and the transparency …
  continue reading
 
This episode delves into the Saudi Food and Drug Authority’s (SFDA) Innovative Medical Devices Pathway (MDS-G002), a strategic initiative designed to significantly accelerate market entry for novel medical technologies in Saudi Arabia. We explore the key features, eligibility criteria, and the profound impact this pathway has on reducing time-to-ma…
  continue reading
 
Jonathan Miller interviews Austin, Texas lobbyist Frank Santos, about the ever-changing state of play for hemp policy in Texas. If you have questions about the episode or ideas for Hemp related topics, email us at [email protected]. Hemp Industry questions covered in the episode: What is Senate Bill 3 and how did it pass the legislatur…
  continue reading
 
This episode unpacks Brazil's transformative RDC 751/2022 medical device regulation, effective since March 1, 2023. We cover the updated four-tier risk classification system, the 22 detailed classification rules (including those for SaMD and nanomaterials) aligning with EU MDR, and the distinct Notification (Class I/II) versus Registration (Class I…
  continue reading
 
In this episode Edye Edens and Darshan Kulkarni tackle a hot-button issue in clinical trials: Should all screen fails be paid for? The discussion was sparked by a recent wave of community questions and contract examples around this very topic. From the sponsor’s perspective, concerns center around cost control and compliance. Sponsors fear that pay…
  continue reading
 
This episode delves into the U.S. FDA's significant 2024 Quality Management System Regulation (QMSR) final rule. We explore how this rule, effective February 2, 2026, aligns 21 CFR Part 820 with the international standard ISO 13485:2016, discuss key changes, FDA-specific additions, and the crucial steps medical device manufacturers must take to pre…
  continue reading
 
This episode delves into the crucial extended transition deadlines for the EU Medical Device Regulation (EU MDR), now set for 2027 and 2028. We explore what these extensions mean for manufacturers of legacy medical devices, emphasizing the critical actions that should have been completed by May and September 2024 to benefit from this extra time. Th…
  continue reading
 
Linda A. Michler, Arbitrator and Mediator, speaks with Christopher C. Murray, Partner, Ogletree Deakins, about arbitration in the health care employment space. They discuss how arbitration works; the strengths and weaknesses of arbitration; and issues related to selecting an arbitrator, cost, mediation, class action waivers, and mass arbitration. T…
  continue reading
 
Did you know that some food dyes can have a negative influence children’s behavior? Join Food Sleuth Radio host and Registered Dietitian, Melinda Hemmelgarn for her conversation with Peter Lurie, MD, MPH, President and Executive Director of the Center for Science in the Public Interest (CSPI), a non-profit food and health watchdog organization base…
  continue reading
 
Loading …

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play